Hesperos has been awarded a NIA Phase IIB SBIR grant to study how combinations of medicines raise the risk of...
The method makes the clinical diagnosis of Parkinson’s disease more precise.
A new drug which has been shown to slow cognitive decline in Alzheimer’s will be ‘welcome news’ for millions of patients.
Researchers in the US are exploring the use of machine learning to predict the advancement of Alzheimer’s disease and give a more accurate timeline of progression....
In a new study, the software has been shown to help stroke survivors regain critical communication skills.
The European Research Council (ERC) has announced €1.5 million in funding for the pioneering project.
Ascentys has secured funding to trial its gaming and AI technology to support early screening of Alzheimer’s disease.
